BioSpace News Archive

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) announced today that it has priced its previously announced offering of $1.6 billion aggregate principal amount of 4.875% senior secured notes due 2028 (the “Notes”).

Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a bioengineering company developing next-generation esophageal implants based its novel Cellframe™ and Cellspan™ technology, today announced its financial results for the three months ended March 31, 2021 .

Electromed was selected for the honor from the 2021 Quality Leadership Top 100 Company survey published annually by the magazine.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced a proposed underwritten public offering in which it intends to offer and sell shares of its common stock.

RedHawk Holdings Corp. (OTC: SNDD) (“RedHawk” or the “Company”), a diversified holding company engaged primarily in sales and distribution of medical devices, reported today a net loss from operations of $425,479 for the nine month period ended March 31, 2021 on gross revenues of $867,841 .

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysis, today announced the appointment of Katie Szyman to its board of directors. Szyman, currently Corporate Vice President and General Manager of Critical Care at Edwards Lifesciences, brings more than 30 years of global medtech leadership experience.

Ginkgo Bioworks, Inc. (“Ginkgo”), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021 , beginning at 1:00pm ET .

Positioned at the forefront of helping people with obstructive sleep apnea (OSA) improve their health and quality of life, AR Medical Technologies launches MaskFit AR. Powered by artificial intelligence and machine learning, MaskFit AR overcomes a 30-year problem of improper patient mask fitment for people who use CPAP or BiPAP TM to treat their OSA.

Nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2 proteins for at least 10 months, according to a new Labcorp (NYSE: LH) analysis of specimens from 39,086 individuals.

Second Quarter: Quarterly sales, operating profit, and earnings per share were all company records Sales were $590 million, an 11% increase over prior year Operating profit was $166 million, a 33% increase over prior year Earnings were $2.12 per diluted share, a 34% increase over prior year